- United States
- /
- Electronic Equipment and Components
- /
- NasdaqGM:MASS
908 Devices Full Year 2022 Earnings: EPS Misses Expectations
908 Devices (NASDAQ:MASS) Full Year 2022 Results
Key Financial Results
- Revenue: US$46.9m (up 11% from FY 2021).
- Net loss: US$33.6m (loss widened by 51% from FY 2021).
- US$1.07 loss per share (further deteriorated from US$0.79 loss in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
908 Devices EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 5.5%.
Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Electronic industry in the US.
Performance of the American Electronic industry.
The company's shares are up 7.6% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 3 warning signs for 908 Devices you should know about.
Mobile Infrastructure for Defense and Disaster
The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.
Get the investor briefing before the next round of contracts
Sponsored On Behalf of CiTechValuation is complex, but we're here to simplify it.
Discover if 908 Devices might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqGM:MASS
908 Devices
A commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices for use in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets.
Excellent balance sheet and fair value.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Airbnb Stock: Platform Growth in a World of Saturation and Scrutiny
Adobe Stock: AI-Fueled ARR Growth Pushes Guidance Higher, But Cost Pressures Loom
Thomson Reuters Stock: When Legal Intelligence Becomes Mission-Critical Infrastructure
Popular Narratives

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
